ARCHIVES

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

RFAs For Extramural Construction, Mouse Facility Available

March 2, 1990

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

Loehrer To Direct IU Simon Cancer Center

March 5, 2010

In Brief: Organ systems Coordinating Center Decision Still Delayed; Branch Merged With DCPC Centers Branch

June 29, 1984

Also in this 8-page issue: Bush nominates McClellan to head CMS.

February 27, 2004